Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations.

Second malignancies following treatment for osteosarcoma are unusual. Breast cancer occurring in patients with osteosarcoma has been reported following therapeutic chest irradiation. We now report three cases of breast cancer occurring in young women who were successfully treated for osteosarcoma. These women had not received therapeutic chest irradiation and in two of the three women there was no family history of breast cancer. Peripheral blood was available for study from one case. Of import, this case demonstrated a germline mutation in exon 7 of the tumor suppressor gene, p53. The mutation was detected by constant denaturing gradient gel electrophoresis and confirmed by DNA sequencing. In this particular patient, inactivation of the p53 gene may be involved in the development of both the first and second malignancy.

[1]  P. Voûte,et al.  Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. , 2006, Medical and pediatric oncology.

[2]  S. Friend,et al.  Screening for germ line TP53 mutations in breast cancer patients. , 1992, Cancer research.

[3]  R. Weichselbaum,et al.  Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.

[4]  S. Friend,et al.  Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.

[5]  S. Friend,et al.  Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Pappo,et al.  Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma , 1991, Cancer.

[7]  V. Sheffield,et al.  Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Dubé,et al.  Acute lymphoblastic leukemia with T(4;11) translocation after osteogenic sarcoma , 1991, Cancer.

[9]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[10]  P. H. Jones,et al.  Identification of factors associated with high breast cancer risk in the mothers of children with soft tissue sarcoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  F. Behm,et al.  Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.

[12]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[13]  G. Draper,et al.  Incidence of second primary tumours among childhood cancer survivors. , 1987, British Journal of Cancer.

[14]  H. B. Marsden,et al.  Patterns of multiple primary tumours in patients treated for cancer during childhood. , 1987, British Journal of Cancer.

[15]  H. B. Marsden,et al.  Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma. , 1986, British Journal of Cancer.

[16]  R. Olsen.  Risk of second cancer after cancer in childhood , 1986, Cancer.

[17]  O. Oberlin,et al.  Second malignant neoplasms in children: an update from the Late Effects Study Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Sallan,et al.  Second neoplasms after Wilms' tumor in childhood. , 1983, Journal of the National Cancer Institute.

[19]  S. Sallan,et al.  Breast carcinoma after cancer therapy in childhood , 1983, Cancer.

[20]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[21]  C. Eggers,et al.  CANCER OF THE BREAST , 1941, Annals of surgery.

[22]  N. Jaffe,et al.  Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma. , 1992, Medical and pediatric oncology.

[23]  C. Land.  Commentary 1 to Schull and Weiss: Low Dose Extrapolation, Time Following Exposure, and Transport between Populations , 1992 .

[24]  G. Vawter,et al.  Bone sarcomas as second malignant neoplasms following childhood cancer , 1991, Cancer.

[25]  Knowling Ma,et al.  Breast cancer after treatment for osteosarcoma. , 1986 .